Here are the first quarter sales or revenue for publicly traded orthopedic device companies, or the spine divisions of larger organizations.
Johnson & Johnson
Spine and other sales: $788 million (2.2 percent decrease)
More information
Stryker
Neurotechnology and spine sales: $700 million (20.7 percent increase)
More information
Medtronic Spine*
Revenue: $691 million (1.1 percent decrease)
More information
NuVasive
Revenue: $274.8 million (5.5 percent increase)
More information
Zimmer Biomet
Spine and craniomaxillofacial sales: $183 million (flat)
More information
Globus Medical
Sales: $182.9 million (5 percent increase)
More information
Orthofix
Spine sales $85.9 million (5.8 percent increase)
More information
RTI Surgical
Revenue: $69.7 million (0.2 percent decrease)
More information
SeaSpine
Revenue: $36.2 million (9 percent increase)
More information
Alpahtec Spine
Revenue: $24.6 million (15 percent increase)
More information
*indicates Q4 of fiscal year 2019